Literature DB >> 23601648

Analysis of chemical and biological features yields mechanistic insights into drug side effects.

Miquel Duran-Frigola1, Patrick Aloy.   

Abstract

Side effects (SEs) are the unintended consequence of therapeutic treatments, but they can also be seen as valuable readouts of drug effects, resulting from the perturbation of biological systems by chemical compounds. Unfortunately, biology and chemistry are often considered separately, leading to incomplete models unable to provide a unified view of SEs. Here, we investigate the molecular bases of over 1,600 SEs by navigating both chemical and biological spaces. We identified characteristic molecular traits for 1,162 SEs, 38% of which can be explained using solely biological arguments, and only 6% are exclusively associated with the chemistry of the compounds, implying that the drug action is somewhat unspecific. Overall, we provide mechanistic insights for most SEs and emphasize the need to blend biology and chemistry to surpass intricate phenomena not captured in the molecular biology view.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23601648     DOI: 10.1016/j.chembiol.2013.03.017

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  16 in total

1.  Auto-Generated Physiological Chain Data for an Ontological Framework for Pharmacology and Mechanism of Action to Determine Suspected Drugs in Cases of Dysuria.

Authors:  Masayo Hayakawa; Takeshi Imai; Yoshimasa Kawazoe; Kouji Kozaki; Kazuhiko Ohe
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

2.  EMBO conference series: Chemical Biology 2014.

Authors:  Eileen J Kennedy
Journal:  Chembiochem       Date:  2014-10-16       Impact factor: 3.164

Review 3.  Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms.

Authors:  Mary Regina Boland; Alexandra Jacunski; Tal Lorberbaum; Joseph D Romano; Robert Moskovitch; Nicholas P Tatonetti
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-11-12

4.  Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker.

Authors:  Miquel Duran-Frigola; Eduardo Pauls; Oriol Guitart-Pla; Martino Bertoni; Víctor Alcalde; David Amat; Teresa Juan-Blanco; Patrick Aloy
Journal:  Nat Biotechnol       Date:  2020-05-18       Impact factor: 54.908

5.  A chemo-centric view of human health and disease.

Authors:  Miquel Duran-Frigola; David Rossell; Patrick Aloy
Journal:  Nat Commun       Date:  2014-12-01       Impact factor: 14.919

6.  Concordance and predictive value of two adverse drug event data sets.

Authors:  Aurel Cami; Ben Y Reis
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-22       Impact factor: 2.796

7.  Systems pharmacology augments drug safety surveillance.

Authors:  T Lorberbaum; M Nasir; M J Keiser; S Vilar; G Hripcsak; N P Tatonetti
Journal:  Clin Pharmacol Ther       Date:  2014-12-20       Impact factor: 6.875

8.  The SIDER database of drugs and side effects.

Authors:  Michael Kuhn; Ivica Letunic; Lars Juhl Jensen; Peer Bork
Journal:  Nucleic Acids Res       Date:  2015-10-19       Impact factor: 16.971

9.  STITCH 4: integration of protein-chemical interactions with user data.

Authors:  Michael Kuhn; Damian Szklarczyk; Sune Pletscher-Frankild; Thomas H Blicher; Christian von Mering; Lars J Jensen; Peer Bork
Journal:  Nucleic Acids Res       Date:  2013-11-28       Impact factor: 16.971

10.  A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions.

Authors:  Allan Peter Davis; Thomas C Wiegers; Phoebe M Roberts; Benjamin L King; Jean M Lay; Kelley Lennon-Hopkins; Daniela Sciaky; Robin Johnson; Heather Keating; Nigel Greene; Robert Hernandez; Kevin J McConnell; Ahmed E Enayetallah; Carolyn J Mattingly
Journal:  Database (Oxford)       Date:  2013-11-28       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.